The Financial AnalystStem Cells Market Complete Study with Business Outlook 2018The Financial AnalystOrbisResearch.com has published new research report on “The Global Market for Stem Cells” to its database. Report Scope: This report discusses the impl… Continue reading
CBS News |
Immunotherapy scores big win against lung cancer in study
CBS News CHICAGO — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success … Immunotherapy transforms lung cancer, the biggest cancer killerNBCNews.com Treatment combo nearly doubles survival time in lung cancer patients, study findsCNN Merck Immunotherapy Drug Shines In Lung Cancer StudyWNCW Washington Post –New York Times –Merck.com –American Cancer Society all 62 news articles » |
Foreign Affairs |
The Ultimate Life Hacker
Foreign Affairs At the age of 12, Jennifer Doudna read James Watson’s The Double Helix and got hooked on science in general and genetics in particular. Four decades later, she is a molecular biology professor at the University of California, Berkeley, an investigator … |
Foreign Affairs |
The Ultimate Life Hacker
Foreign Affairs At the age of 12, Jennifer Doudna read James Watson’s The Double Helix and got hooked on science in general and genetics in particular. Four decades later, she is a molecular biology professor at the University of California, Berkeley, an investigator … |
Business Insider |
Why Bristol-Myers Squibb is making a big bet its approach to treating lung cancer is the right one
Business Insider A new batch of data on Monday showed how immunotherapy, a new kind of cancer treatment that harnesses the body’s immune system, works in lung cancer patients. Among the data were results on how Bristol-Myers Squibb’s combination of two immunotherapy … Global Immunotherapy Drugs Market 2018 Review- Eli Lilly, Merck-Pfizer, Bristol Myers Squibb, Dendreon (Valeant …The Financial |